Back To: Home : Featured Technology : Stem Cell

CLICK HERE FOR WHAT'S NEW IN:
 

Boning up on research
05-08-2006
by Randall C. Willis  |  Email the author
SHARING OPTIONS:

FREEHOLD, N.J.—Further expanding commercialization of European products, New Life Scientific (NWLS) announced a strategic alliance with Biorigen Srl, a biotech company, and Centro Biotecnologie Avanzate, both based in Genoa, Italy, to push tissue engineering for bone repair. Under the agreement, NWLS will retain global rights, with the exception of the European Union and countries of the Mediterranean Basin and Middle East, to any products arising from the joint venture.
 
The bone reconstruction project will be based on technology that expands mesechymal stem cells in culture for more efficient and reproduceable healing. Biorigen will be responsible for preclinical product development, but will then work with NWLS to push the product through the clinical process. NWLS will then take over the registration and marketing in assigned market territories.

Back


PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2018 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.